Tania Azad
Global Program Director, Late Phase Clinical Operations Alexion Pharmaceuticals
Tania Azad is Global Program Director, Late Phase Clinical Operations at Alexion Pharmaceuticals, with extensive experience across global clinical research and clinical operations. Her career has included clinical programme leadership roles at Alexion and AstraZeneca, alongside earlier experience in clinical trial management and research. Tania brings a global operational perspective to early access, with a particular interest in how access programmes intersect with clinical research and the broader development pathway.
Seminars
Tuesday 23rd March 2027
Workshop B – Building SOPs, Governance Structures & Internal Alignment for New Expanded Access Teams
11:00 am
- Defining ownership across Medical, Regulatory, Clinical Operations and Supply
- Determining which clinical trial processes should be adapted for EAPs
- Building governance structures and approval workflows
- Securing internal buy-in and managing cross-functional stakeholders
Wednesday 24th March 2027
Building an Operational Framework for Post-Trial Access
1:30 pm
- Translating Post-Trial Access strategy into a practical operational framework that can be applied consistently across programs
- Defining the processes, roles and cross-functional responsibilities needed to operationalize Post-Trial Access effectively
- Sharing practical examples and lessons learned from managing Post-Trial Access, including common hurdles and how they have been overcome
- Building a framework that supports consistent decision-making while allowing teams to respond to different program and country requirements
